Related Experiment Videos
Candidate epitope identification using peptide property models: application to cancer immunotherapy
Myong-Hee Sung1, Richard Simon
1Molecular Statistics and Bioinformatics Section, Biometric Research Branch, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd. EPN 8146, MSC 7434, Bethesda, MD 20892, USA. sungm@mail.nih.gov
Methods (San Diego, Calif.)
|November 16, 2004
Summary
This study introduces a novel bioinformatical method to predict T cell epitopes by analyzing peptide-major histocompatibility complex (MHC) binding. This approach aids in developing effective anti-cancer vaccines by identifying potential targets for diverse populations.
Area of Science:
- Immunology
- Bioinformatics
- Oncology
Background:
- Major histocompatibility complex (MHC) proteins present peptides from pathogens or tumors to T lymphocytes, initiating immune responses.
- T cell recognition of antigenic peptide-MHC complexes activates T cells against target cells.
- Identifying peptides that bind multiple MHC molecules is crucial for vaccine design targeting diverse populations.
Purpose of the Study:
- To develop a new bioinformatical method for predicting MHC-binding peptides.
- To facilitate the identification of T cell epitopes for vaccine development.
- To apply the method for identifying potential T cell epitopes in melanoma and breast cancer.
Main Methods:
- Constructed peptide property models using biophysical parameters of amino acids and a training set of known binders.
- Developed a computational algorithm to predict MHC-binding peptides.
- Analyzed over-expressed proteins in cancer cells (e.g., MART-1, p53) for potential T cell epitopes.
Main Results:
- The developed models predict MHC-binding peptides with potential as T cell epitopes.
- The method was applied to identify candidate epitopes for melanoma and breast cancer.
- Model predictions were compared with available experimental data.
Conclusions:
- The bioinformatical approach provides an efficient strategy for identifying T cell epitopes.
- This method can aid in the development of anti-tumor vaccines.
- Experimental validation of computationally identified epitopes is essential for immunotherapy development.